Pyxis Oncology, Inc. (PYXS) Misses Q4 EPS by 100c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts PYXS Hot Sheet
Join SI Premium – FREE
Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q4 EPS of ($1.32), $1.00 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Updates US Conviction List Directors' Cut
- Oxford Square Capital Corp. (OXSQ) Misses Q3 EPS by 1c
- Citi reiterates buy rating on Symbotic with $70 price target
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
